Gram classification of positive blood cultures is associated with mortality outcomes in septic acute kidney injury requiring continuous renal replacement therapy

Author:

Lee Jinwoo1,Song Jeongin2,Kim Seong Geun3,Yun Donghwan2,Kang Min Woo2,Kim Dong Ki2,Oh Kook-Hwan2,Joo Kwon Wook2,Kim Yon Su2,Han Seung Seok2,Park Jae Yoon1,Kim Yong Chul2

Affiliation:

1. Dongguk University Ilsan Hospital

2. Seoul National University Hospital, Seoul National University College of Medicine

3. Inje University Sanggye Paik Hospital

Abstract

Abstract Sepsis is one of the most common causes of AKI in ICU patients, accounting for 15–20% of renal replacement therapy prescriptions. Herein, we aimed to investigate how bacterial blood culture results before CRRT correlate with mortality outcomes in patients with septic AKI requiring CRRT. The enrolled patients were divided into culture-negative, gram-positive, and gram-negative. Since the use of empirical antibiotics can affect culture-positive determination, information on antibiotic use was collected in chronological order. The primary outcome was in-hospital mortality after the initiation of CRRT. A total of 874 septic AKI patients requiring CRRT were classified into three groups: culture-negative, gram-positive cocci, and gram-negative rods. Their in-hospital mortality rates were 79.1%, 75.7%, and 61.9%, respectively (P = 0.002). In univariable Cox survival analysis performed after matching propensity scores, the gram-negative rod group was still associated with an approximately 37% reduction in mortality compared to the culture-negative group. The survival benefit of the gram-negative rod group during and after CRRT remained consistent across all subgroups, showing any P for interactions greater than 0.05. Culture-positive of gram-negative rods before CRRT initiation determine subsequent better clinical outcomes, such as lower mortality in patients undergoing CRRT due to septic AKI.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3